234 related articles for article (PubMed ID: 33985854)
21. Longitudinal evaluation of dehydroepiandrosterone (DHEA), its sulfated form and estradiol with cancer-related cognitive impairment in early-stage breast cancer patients receiving chemotherapy.
Toh YL; Tan CJ; Yap NY; Parajuli R; Lau AJ; Chan A
Sci Rep; 2022 Oct; 12(1):16552. PubMed ID: 36192413
[TBL] [Abstract][Full Text] [Related]
22. Strong Association of Serum GSK-3β/BDNF Ratio with Mild Cognitive Impairment in Elderly Type 2 Diabetic Patients.
Du B; Lian Y; Chen C; Zhang H; Bi Y; Fan C; Bi X
Curr Alzheimer Res; 2019; 16(12):1151-1160. PubMed ID: 31453785
[TBL] [Abstract][Full Text] [Related]
23. Associations between inflammatory markers and cognitive function in breast cancer patients receiving chemotherapy.
Williams AM; Shah R; Shayne M; Huston AJ; Krebs M; Murray N; Thompson BD; Doyle K; Korotkin J; van Wijngaarden E; Hyland S; Moynihan JA; Cory-Slechta DA; Janelsins MC
J Neuroimmunol; 2018 Jan; 314():17-23. PubMed ID: 29128118
[TBL] [Abstract][Full Text] [Related]
24. Serum brain-derived neurotrophic factor levels in relation to comorbid depression and cytokine levels in Nepalese men with alcohol-use disorders.
Neupane SP; Lien L; Ueland T; Mollnes TE; Aukrust P; Bramness JG
Alcohol; 2015 Aug; 49(5):471-8. PubMed ID: 25873205
[TBL] [Abstract][Full Text] [Related]
25. Brain-derived neurotrophic factor genetic polymorphism (rs6265) is protective against chemotherapy-associated cognitive impairment in patients with early-stage breast cancer.
Ng T; Teo SM; Yeo HL; Shwe M; Gan YX; Cheung YT; Foo KM; Cham MT; Lee JA; Tan YP; Fan G; Yong WS; Preetha M; Loh WJ; Koo SL; Jain A; Lee GE; Wong M; Dent R; Yap YS; Ng R; Khor CC; Ho HK; Chan A
Neuro Oncol; 2016 Feb; 18(2):244-51. PubMed ID: 26289590
[TBL] [Abstract][Full Text] [Related]
26. Changes in plasma IL-1β, TNF-α and IL-4 levels are involved in chemotherapy-related cognitive impairment in early-stage breast cancer patients.
Zhao J; Zuo H; Ding K; Zhang X; Bi Z; Cheng H
Am J Transl Res; 2020; 12(6):3046-3056. PubMed ID: 32655829
[TBL] [Abstract][Full Text] [Related]
27. Plasma concentrations but not serum concentrations of brain-derived neurotrophic factor are related to pro-inflammatory cytokines in patients undergoing major abdominal surgery.
Chimienti G; Mezzapesa A; Rotelli MT; Lupo L; Pepe G
Clin Biochem; 2012 Jun; 45(9):631-6. PubMed ID: 22425604
[TBL] [Abstract][Full Text] [Related]
28. Genetic risk factors for cancer-related cognitive impairment: a systematic review.
Buskbjerg CDR; Amidi A; Demontis D; Nissen ER; Zachariae R
Acta Oncol; 2019 May; 58(5):537-547. PubMed ID: 30822178
[No Abstract] [Full Text] [Related]
29. Cognitive impairment and BDNF serum levels.
Siuda J; Patalong-Ogiewa M; Żmuda W; Targosz-Gajniak M; Niewiadomska E; Matuszek I; Jędrzejowska-Szypułka H; Lewin-Kowalik J; Rudzińska-Bar M
Neurol Neurochir Pol; 2017; 51(1):24-32. PubMed ID: 28341039
[TBL] [Abstract][Full Text] [Related]
30. Relationships between serum brain-derived neurotrophic factor, plasma catecholamine metabolites, cytokines, cognitive function and clinical symptoms in Japanese patients with chronic schizophrenia treated with atypical antipsychotic monotherapy.
Hori H; Yoshimura R; Katsuki A; Atake K; Igata R; Konishi Y; Nakamura J
World J Biol Psychiatry; 2017 Aug; 18(5):401-408. PubMed ID: 27409727
[TBL] [Abstract][Full Text] [Related]
31. BDNF, TNFα, HSP90, CFH, and IL-10 serum levels in patients with early or late onset Alzheimer's disease or mild cognitive impairment.
Gezen-Ak D; Dursun E; Hanağası H; Bilgiç B; Lohman E; Araz ÖS; Atasoy IL; Alaylıoğlu M; Önal B; Gürvit H; Yılmazer S
J Alzheimers Dis; 2013; 37(1):185-95. PubMed ID: 23948885
[TBL] [Abstract][Full Text] [Related]
32. Plasma levels of IL-1Ra are associated with schizophrenia.
Zhou Y; Peng W; Wang J; Zhou W; Zhou Y; Ying B
Psychiatry Clin Neurosci; 2019 Mar; 73(3):109-115. PubMed ID: 30375100
[TBL] [Abstract][Full Text] [Related]
33. Brain-derived neurotrophic factor as a biomarker for cognitive recovery in acute schizophrenia: 12-week results from a prospective longitudinal study.
Zhang Y; Fang X; Fan W; Tang W; Cai J; Song L; Zhang C
Psychopharmacology (Berl); 2018 Apr; 235(4):1191-1198. PubMed ID: 29392373
[TBL] [Abstract][Full Text] [Related]
34. Role of Cytokines in Chemotherapy-related Cognitive Impairment of Breast Cancer Patients: A Systematic Review.
Tyagi K; Masoom M; Majid H; Garg A; Bhurani D; Agarwal NB; Khan MA
Curr Rev Clin Exp Pharmacol; 2023; 18(2):110-119. PubMed ID: 35249524
[TBL] [Abstract][Full Text] [Related]
35. Cancer-related cognitive impairment: an update on state of the art, detection, and management strategies in cancer survivors.
Lange M; Joly F; Vardy J; Ahles T; Dubois M; Tron L; Winocur G; De Ruiter MB; Castel H
Ann Oncol; 2019 Dec; 30(12):1925-1940. PubMed ID: 31617564
[TBL] [Abstract][Full Text] [Related]
36. Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression.
Jehn CF; Becker B; Flath B; Nogai H; Vuong L; Schmid P; Lüftner D
J Neuroimmunol; 2015 Oct; 287():88-92. PubMed ID: 26439967
[TBL] [Abstract][Full Text] [Related]
37. Brain-derived neurotrophic factor and inflammatory markers in school-aged children with early trauma.
Bücker J; Fries GR; Kapczinski F; Post RM; Yatham LN; Vianna P; Bogo Chies JA; Gama CS; Magalhães PV; Aguiar BW; Pfaffenseller B; Kauer-Sant'Anna M
Acta Psychiatr Scand; 2015 May; 131(5):360-8. PubMed ID: 25401224
[TBL] [Abstract][Full Text] [Related]
38. Peripheral inflammatory and neurotrophic biomarkers of cognitive impairment in schizophrenia: a meta-analysis.
Bora E
Psychol Med; 2019 Sep; 49(12):1971-1979. PubMed ID: 31284882
[TBL] [Abstract][Full Text] [Related]
39. Peripheral Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease and Mild Cognitive Impairment: a Comprehensive Systematic Review and Meta-analysis.
Kim BY; Lee SH; Graham PL; Angelucci F; Lucia A; Pareja-Galeano H; Leyhe T; Turana Y; Lee IR; Yoon JH; Shin JI
Mol Neurobiol; 2017 Nov; 54(9):7297-7311. PubMed ID: 27815832
[TBL] [Abstract][Full Text] [Related]
40. Preliminary Associations Between Brain-Derived Neurotrophic Factor, Memory Impairment, Functional Cognition, and Depressive Symptoms Following Severe TBI.
Failla MD; Juengst SB; Arenth PM; Wagner AK
Neurorehabil Neural Repair; 2016 Jun; 30(5):419-30. PubMed ID: 26276123
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
